News

Virginia Senate Committee Advances Bill to Legalize Recreational Cannabis Sales

LOS ANGELES- On January 17, 2025, the Virginia Senate Rehabilitation and Social Services Committee approved Senate Bill 970 (SB 970) with an 8–7 vote along party lines. Introduced by Senator Aaron Rouse (D-Virginia Beach), the bill proposes the establishment of a regulated retail market for adult-use cannabis, with sales anticipated to commence on May 1, ...

January 22nd, 2025|Business|

The Important Tax Deadlines to Remember in Cannabis

LOS ANGELES—As we enter 2025, it's crucial for individuals and businesses to keep track of key tax deadlines. Missing these dates can lead to penalties, interest charges, and wasted opportunities for tax savings. At Growise CPAs, we understand the complexities of tax compliance, especially in the cannabis and psychedelic industries. So, let's outline the critical ...

January 21st, 2025|Business, Insights|

Senator Warren Seeks Clarification from RFK Jr. on Cannabis Legalization and Rescheduling

LOS ANGELES- Senator Elizabeth Warren (D-MA) has formally requested that Robert F. Kennedy Jr., the nominee for Secretary of Health and Human Services (HHS), clarify his stance on cannabis legalization and rescheduling. In a comprehensive 34-page letter, Senator Warren posed 175 questions covering various policy areas, including substance abuse, opioid crisis management, and cannabis reform. ...

January 21st, 2025|Insights|

Virginia Officials Advocate for Automatic Sealing of Cannabis Possession Records

LOS ANGELES- Virginia state officials are advocating for legislative measures to automatically seal all criminal records related to simple cannabis possession without the necessity of court orders. The Virginia State Crime Commission (VSCC) has endorsed recommendations to ensure that both convictions and non-convictions for cannabis possession are sealed automatically. Colin Drabert, Deputy Director of VSCC, ...

January 21st, 2025|Insights|

Analysis: Pennsylvania’s Cannabis Industry: Current Growth and Future Projections

NEW YORK- The cannabis industry in Pennsylvania continues to evolve, with medical cannabis already generating over $1.5 billion in annual sales. Discussions about recreational legalization are intensifying, particularly as the state's budget deficit grows and bipartisan support builds. Industry experts, including those at Viridian Capital Advisors, foresee substantial economic opportunities if recreational cannabis is approved. ...

January 20th, 2025|Business, Insights|

Week In Review: Arkansas Governor Proposes Funding Free School Meals with Medical Cannabis Tax Revenue; Biden Commutes Sentences of Nearly 2,500 Nonviolent Drug Offenders; Hemp-Derived CBD Market Set to Expand Significantly by 2034

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it!  Cannabis Industry Highlights #1) Arkansas Governor Proposes Funding Free School Meals with Medical Cannabis Tax ...

January 20th, 2025|Business, The Week in Review|

Arkansas Governor Proposes Funding Free School Meals with Medical Cannabis Tax Revenue

LOS ANGELES- Arkansas Governor Sarah Huckabee Sanders has announced plans to allocate tax revenue from medical cannabis sales to fund free school meals across the state. In her State of the State address, Governor Sanders stated, "I've already announced that Arkansas will participate in summer EBT this year. And today, I'm announcing my plan to ...

January 20th, 2025|Insights|

Vireo Growth Completes $81 Million Equity Offering

LOS ANGELES- Vireo Growth Inc., a Minneapolis-based cannabis multistate operator, has successfully concluded an oversubscribed private placement, raising approximately $81 million. Initially targeting $75 million, the company issued 129,536,874 subordinate voting shares at $0.625 per share, representing a 16.8% premium over the December 27, 2024, closing price on OTCQX. The net proceeds are earmarked for ...

January 20th, 2025|Capital|

Biden Commutes Sentences of Nearly 2,500 Nonviolent Drug Offenders

LOS ANGELES- President Joe Biden has commuted the sentences of approximately 2,500 individuals convicted of nonviolent drug offenses, marking a significant use of executive clemency. This action aims to address past disparities in drug-related sentencing, particularly those involving crack and powder cocaine. The White House has not released the names of those who received commutations. ...

January 17th, 2025|Justice|

New York Supreme Court Halts Warrantless Raids on Licensed Hemp Retailers

LOS ANGELES- In a recent decision, New York State Supreme Court Justice Thomas Marcelle issued an injunction against the New York State Cannabis Control Board (CCB), the Office of Cannabis Management (OCM), and the New York City Sheriff's Office, prohibiting them from conducting warrantless raids on state-licensed hemp businesses. The court found that these actions ...

January 17th, 2025|Justice|

Indiana Legislators Introduce Cannabis Legalization and Psilocybin Research Bills

LOS ANGELES- Indiana lawmakers have initiated efforts to reform the state's drug policies in the 2025 legislative session, introducing several bills aimed at legalizing cannabis and funding psilocybin research. Cannabis Legalization Proposals Senate Bill 113, sponsored by Senator Rodney Pol (D), seeks to legalize cannabis for both recreational and medical use. The bill proposes establishing ...

January 16th, 2025|Justice|

Colorado Considers Psilocybin Prescription Legislation

LOS ANGELES- Colorado lawmakers have introduced House Bill 25-1063, a bipartisan proposal that would permit the prescription of crystalline polymorph psilocybin—a synthetic form of the psychedelic compound—contingent upon approval by the U.S. Food and Drug Administration (FDA). The bill, sponsored by Representatives Anthony Hartsook (R) and Kyle Brown (D), aims to provide healthcare providers with ...

January 16th, 2025|Psychedelics|

Chairman of High Times Parent Company to Plead Guilty in Fraud Scheme

LOS ANGELES-Adam Levin, chairman of Hightimes Holding Corp., has agreed to plead guilty to conspiracy charges involving a scheme to pay an investment analyst to promote the company’s stock without disclosing the compensation. According to the U.S. Attorney’s Office for the Central District of California, Levin paid over $150,000 to the analyst, who subsequently endorsed ...

January 15th, 2025|Business, Insights|

High Tide Acquires Majority Stake in German Cannabis Firm

LOS ANGELES- High Tide Inc., a Canadian cannabis enterprise, has acquired a 51% stake in Frankfurt-based pharmaceutical company Purecan for approximately €4.8 million. This strategic move marks High Tide's entry into Germany's medical cannabis market. The transaction includes a combination of cash, common shares, and a promissory note. High Tide retains an option to acquire ...

January 15th, 2025|Business|

DEA Judge Cancels Cannabis Rescheduling Hearings

LOS ANGELES- The Drug Enforcement Administration (DEA) has canceled its upcoming hearings on the proposed rescheduling of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney issued the cancellation following legal challenges from pro-reform witnesses, effectively delaying any potential policy changes for at least three months. The hearings, initially set to commence ...

January 15th, 2025|Justice|

Hemp vs Cannabis Beverages: What’s the Difference, and Why Does It Matter?

LOS ANGELES- Cannabis and hemp beverages markets see rapid growth, but their distinctions remain unclear to many. While both originate from one species, they cater to vastly different audiences, serve distinct purposes, and adhere to unique regulatory frameworks. For consumers seeking clarity, manufacturers striving for innovation, and investors identifying opportunities, a deeper understanding of these ...

January 14th, 2025|Business, Insights|

What You Need to Know Inventory Management and Cost Accounting

LOS ANGELES—Every entrepreneur, CEO and CFO needs to know that effective inventory management and accurate cost accounting are critical to success in the cannabis and psychedelic industries. As businesses navigate a landscape marked by strict regulations and intense competition, implementing robust seed-to-sale tracking systems and accurate cost accounting practices are essential to maintaining compliance and ...

January 14th, 2025|Business, Insights|

The Rise of a New Era of Consumption: Cannabis-Infused Drinks

LOS ANGELES--Cannabis-infused beverages have rapidly gained traction in recent years as a popular alternative to traditional consumption methods such as smoking and vaping. With the increasing legalization of cannabis in the United States and other parts of the world, these drinks offer consumers a novel and convenient way to enjoy all the benefits of the ...

January 14th, 2025|Business, Insights|
  • CanPay

Worried About IRS Audits? What You Need to Know

LOS ANGELES– The cannabis and psychedelics industry is undergoing a remarkable transformation, and as we one step into 2025, the outlook is brighter than ever. With increasing legalization, growing consumer acceptance, and a burgeoning market projected to reach nearly $40 billion next year, companies engaged in the sector have every reason to be optimistic. However, ...

January 14th, 2025|Business, Insights|

Psilocybin Therapy Shows Promise for Pandemic-Induced Depression in Healthcare Workers

LOS ANGELES- Recent studies indicate that psilocybin-assisted psychotherapy may alleviate depression among healthcare professionals affected by the COVID-19 pandemic. A randomized clinical trial conducted by the University of Washington involved 30 frontline clinicians experiencing moderate to severe depression. Participants received either a 25 mg dose of psilocybin or a placebo, alongside psychotherapy sessions. The psilocybin group ...

January 14th, 2025|Psychedelics|

Efficacy of Medical Cannabis in Treating PTSD Remains Uncertain

LOS ANGELES- The use of medical cannabis as a treatment for post-traumatic stress disorder (PTSD) has garnered significant attention. However, current research provides limited and inconclusive evidence regarding its effectiveness. A 2021 systematic review found insufficient support for cannabinoids in treating PTSD-related mental health disorders. The review highlighted the need for more rigorous studies to ...

January 14th, 2025|Insights|

Week In Review: Vireo Growth Inc. Secures $75 Million Financing and Acquires Four Cannabis Operators; Minnesota Approves Hemp Seed Meal for Laying Hens Agrify Divests Cultivation Business to Focus on THC Beverages; Aurora Cannabis Expands Distribution in Australia

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it!  Cannabis Industry Highlights #1) Vireo Growth Inc. Secures $75 Million Financing and Acquires Four Cannabis ...

January 13th, 2025|Business, The Week in Review|

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows approval from the UK's Medicines and Healthcare products Regulatory Agency. The Phase 3 program comprises two pivotal trials: COMP 005 ...

January 13th, 2025|Psychedelics|

Hemp-Derived CBD Market Set to Expand Significantly by 2034

LOS ANGELES- The global hemp-derived cannabidiol (CBD) market is forecasted to grow from $8.28 billion in 2023 to $46.25 billion by 2034, with a compound annual growth rate (CAGR) of 16.93%, according to Research and Markets. This expansion is driven by increased consumer preference for natural wellness products, regulatory developments, and growing applications in personal ...

January 10th, 2025|Insights|

DEA Faces Allegations of Bias in Cannabis Rescheduling Process

LOS ANGELES- The Drug Enforcement Administration (DEA) is under scrutiny following allegations of bias in its handling of the cannabis rescheduling process. Pro-cannabis advocates assert that the agency has demonstrated an "unalterably closed mind" toward reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. Critics argue that the DEA has engaged ...

January 10th, 2025|Justice|
Go to Top